Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...

In a Chinese trial, trastuzumab rezetecan induced a 73% response rate in previously treated HER2-mutant non-small cell lung cancer (NSCLC). The safety profile of the novel antibody-drug conjugate was ...

Secretary, Measles-dismisser, nepo-baby, bear cub-dumper, and vaccine skeptic, Robert F. Kennedy, Jr., was one of the ...

Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...

The company's investment will expand its US manufacturing footprint and is the largest investment of its kind in history.

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...